Key result
The presence of vasomotor symptoms was significantly associated with an increased risk of metabolic syndrome in postmenopausal women (OR 1.8; 95% CI 1.3-2.4; P<0.001).
Why the study?
Is the presence of vasomotor symptoms associated with an increased risk of metabolic syndrome in postmenopausal women?
Cross-Sectional (n=1,906)
No
Is the presence of vasomotor symptoms associated with an increased risk of metabolic syndrome in postmenopausal women?
Vasomotor symptoms in postmenopausal women are independently associated with an 80% increased odds of metabolic syndrome, suggesting they may serve as an early clinical marker for cardiovascular risk.
Answers are grounded in this paper and cite their sources.
Vasomotor symptoms were associated with metabolic syndrome in postmenopausal women; leaves open causality and need for longitudinal confirmation.
OBJECTIVE: This study aims to evaluate the association between vasomotor symptoms and risk of metabolic syndrome in Korean postmenopausal women. METHODS: We carried out a cross-sectional study of 1,906 Korean postmenopausal women (aged 45-65 y) who were attending a routine health checkup at an institution in Korea from January 2010 to December 2012. To assess vasomotor symptoms, we created a dichotomous variable (none or present) using Menopause Rating Scale results. Metabolic syndrome was defined by the updated criteria of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). RESULTS: In total, 1,906 women were included in the analysis; 1,105 (58.0%) women reported some degree of vasomotor symptoms. Women with vasomotor symptoms were younger and had shorter duration of menopause, higher body mass index, larger waist circumference, more adverse lipid profile, and higher prevalence of metabolic syndrome compared with women without vasomotor symptoms. On multivariate analysis, vasomotor symptoms were associated with metabolic syndrome after adjusting for confounding factors, including age, body mass index, homeostasis model assessment of insulin resistance, duration of menopause, alcohol consumption, current smoking, and physical exercise level (odds ratio, 1.8; 95% CI, 1.3-2.4; P < 0.001). CONCLUSIONS: The presence of vasomotor symptoms is associated with metabolic syndrome in Korean postmenopausal women. Lipid abnormalities and obesity seem to be important metabolic components associated with these symptoms. Vasomotor symptoms, if validated in longitudinal studies, may possibly serve as warning signs for identifying women at high risk for metabolic syndrome and cardiovascular disease.
No takes yet. Share an insight, caveat, or question.
Ryu et al. (2015) conducted a cross-sectional in Postmenopausal women (n=1,906). Vasomotor symptoms vs. No vasomotor symptoms was evaluated on Metabolic syndrome (OR 1.8, 95% CI 1.3-2.4, p=<0.001). The presence of vasomotor symptoms was significantly associated with an increased risk of metabolic syndrome in postmenopausal women (OR 1.8; 95% CI 1.3-2.4; P<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: